Polish Multicenter PERTs PE Outcomes Registry

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

10000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-06-01

Study Completion Date

2030-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Pulmonary embolism (PE) is the third leading cause of cardiovascular mortality. The Pulmonary Embolism Response Team (PERT) concept offers a rapid and multidisciplinary approach focused on improving outcomes for patients with PE. All institutionalized PERTs in Poland have been invited to join the study. The goal of this registry is to describe current practice and outcomes in patients with acute PE treated by Polish PERTs.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinical Outcomes After Acute Pulmonary Embolism

NCT04355975

Pulmonary Embolism

RECRUITING

Surgery in Pulmonary Embolisms

NCT06070129

Pulmonary Embolism

NOT_YET_RECRUITING

Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-I

NCT06571760

Pulmonary Embolism

COMPLETED NA

Pulmonary Embolism Short-term Clinical Outcomes Registry

NCT02883491

Pulmonary Embolism

COMPLETED

Changes of Cardiopulmonary Function After Thrombolysis in Patients With Pulmonary Embolism

NCT04757129

Acute Pulmonary Embolism

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Pulmonary embolism (PE) is the third leading cause of cardiovascular mortality. The presentation of PE may vary from asymptomatic or mild exertion disturbances (low-risk PE) treated with anticoagulants only to hemodynamic "obstructive" collapse and death (high-risk PE). Patient outcome depends on ability of the right ventricle to sustain the increased afterload caused by the embolic burden. Careful risk stratification is crucial, and the Pulmonary Embolism Response Team (PERT) concept offers a rapid and multidisciplinary approach focused on improving outcomes for patients with PE by advancing its recognition, diagnosis, and treatment. All institutionalized PERTs in Poland have been invited to join the study. The data is administrated by the Poznan University of Medical Sciences on the basis of an agreement between the PERT centres.

The goal of this registry is to describe current practice and outcomes in patients with acute PE guided by Polish PERTs. The primary data recorded include details of each patient's clinical status, co-morbidities, the administered treatment modalities, the results of additional studies (ab tests results, ECG, imaging studies), and the outcome.

The data collection will have no impact on the way the patient is diagnosed and treated.The study endpoints comprise respiratory failure, shock, death distal systemic embolization (i.e. stroke) and major or minor bleeding complications classified according to the International Society on Thrombosis and Haemostasis classification.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Embolism With Acute Cor Pulmonale

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intermediate-high risk PE

Confirmed PE causing right ventricle dysfunction confirmed by computed tomography pulmonary angiography or transthoracic echocardiography and elevated troponin level

No interventions assigned to this group

High-risk PE

Confirmed PE causing hemodynamic instability:

1. Cardiac arrest (need for cardiopulmonary resuscitation) or,
2. Obstructive shock (systolic blood pressure \< 90 mmHg or vasopressors required to achieve a systolic blood pressure ≥90 mmHg despite adequate filling status and end-organ hypoperfusion), or
3. Persistent hypotension (systolic blood pressure \< 90 mmHg for at least 15 minutes)

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. PE confirmed by computed tomography pulmonary angiography.
2. PE symptoms duration ≤ 14 days.
3. High-risk PE with hemodynamic instability (one of):

* cardiac arrest
* obstructive shock
* persistent hypotension.
4. Intermediate-high risk PE patients with right ventricle dysfunction confirmed by imaging studies and elevated troponin level.